Arrivent BioPharma, Inc. (AVBP)
20.86
-1.04
(-4.75%)
USD |
NASDAQ |
Jan 16, 16:00
20.84
-0.02
(-0.10%)
After-Hours: 20:00
Arrivent BioPharma Market Cap: 846.27M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 8.374B |
| AIM ImmunoTech, Inc. | 3.942M |
| Annexon, Inc. | 904.77M |
| Spruce Biosciences, Inc. | 41.40M |
| CEL-SCI Corp. | 15.63M |
Market Cap Related Metrics
| PEG Ratio | -0.0654 |
| Price to Book Value | 2.775 |
| Price | 20.86 |
| Earnings Yield | -20.30% |
| PEGY Ratio | -0.0654 |